InvestorsHub Logo
Followers 5
Posts 423
Boards Moderated 0
Alias Born 04/11/2010

Re: None

Monday, 07/01/2019 10:15:46 AM

Monday, July 01, 2019 10:15:46 AM

Post# of 232933

“Each diagnostic test may use 20 micro mg (mcg) of PRO 140 (1 mg = 1,000 mcg), implying significant revenue opportunity for CytoDyn, since any use of leronlimab for commercial purposes will require this diagnostic test.



So they have a diagnostic test which could start generating revenue in August which is linked to a product (Leronlimab) which will be (hopefully) on market somewhere in 2020?
Do they want to sell this test somehow for Maraviroc applications? Otherwise this does not make any sense for me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News